Le Lézard
Classified in: Health, Business
Subjects: TNM, CXP

AvevoRx Expands to Maine, Making Specialty Pharmacy Infusion Services Available to Patients Statewide


Company's latest service area expansion punctuates its continued growth momentum and strengthens its position as a national provider

GREENSBORO, N.C., April 16, 2024 /PRNewswire-PRWeb/ -- AvevoRx, an independent provider of specialty infusion pharmacy services for patients facing various complex or chronic disorders, has extended its service area to include the state of Maine. The announcement of its latest service area licensure expansion follows the company's recent expansions into several new states in Q1 of this year, highlighting its rapid growth momentum. AvevoRx now offers its services to patients in over 30 states nationwide, covering approximately 73 percent of the U.S. population.

"Our objective is to help ensure that patients across the country have access to specialized infusion treatments," said Robin Johnson, Chief Financial Officer for AvevoRx. "By expanding our geographic coverage, we can offer more support to the patients who need it the most."

A truly national provider, AvevoRx plans to continue expanding across the United States throughout 2024. Recently, the company announced new licensure expansions in Minnesota, Washington State, Kansas, and the Dakotas. Since its establishment, AvevoRx has exceeded market expectations through several strategic acquisitions and organic growth.

"Our objective is to help ensure that patients across the country have access to specialized infusion treatments," said Robin Johnson, Chief Financial Officer for AvevoRx. "By expanding our geographic coverage, we can offer more support to the patients who need it the most."

Eric Hill, AvevoRx co-founder, added, "Each expansion brings us greater reach across much of the country while we zero in on areas with the greatest need for our services. We continuously refine and improve our operations to reflect our core principles and help scale our high-touch, high-service model."

AvevoRx began as a startup in Greensboro, North Carolina, founded in 2021 by a team of industry veterans with 130 years of combined experience. By November of that year, it acquired Mid Valley Health Services, a long-established infusion company based in Modesto, CA. In September 2022, AvevoRx entered an agreement to acquire Access to Care, LLC, an independent home infusion pharmacy in Muncie, IN. Today, both companies operate under the AvevoRx name.

To refer a patient or to get more information on the specialty infusion solutions provided by AvevoRx, call us at 877-AvevoRx or contact us through our website. Learn more at AvevoRx.com.

About AvevoRx

AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.

Media Contact

Victoria Seremeta, AvevoRx, 1 5162861950, [email protected], www.avevorx.com 

SOURCE AvevoRx


These press releases may also interest you

at 01:30
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the...

at 01:00
Management Report1 Q1 2024 highlights Strong performance in Perfumery & Beauty on good demand developmentGood performance in Taste, Texture & Health underpinned by market recoveryHealth, Nutrition & Care was soft, with improving momentum by end of...

at 00:01
Today, the Conference on Jewish Material Claims Against Germany (Claims Conference) launched a new digital campaign, #CancelHate. The campaign features Holocaust survivors reading Holocaust denial posts from across social media platforms. Each post...

at 00:00
With over four decades of nursing experience under her belt, Sherry Shaffer Ratajczak has witnessed firsthand the dedication of her colleagues in patient care. Yet, she observed a common misunderstanding: many are unaware of the extensive knowledge...

1 mai 2024
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

1 mai 2024
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...



News published on and distributed by: